Tag: Osteoporosis
Young Breast Cancer Patients Face Higher Risk for Osteoporosis
Women diagnosed before age 50 have twice the risk versus cancer-free peers
Denosumab Promising for TDT-Induced Osteoporosis Treatment
Higher percentage increase of L1 to L4 and wrist bone mineral density with DMN, reduction in pain
Drop in Osteoporosis Treatment Initiation After Hip Fracture
Adherence to regimen needed to cut subsequent fracture risk
USPSTF Favors Osteoporosis Screening to Prevent Fracture
Screening with bone measurement recommended for women aged ≥65, younger women at risk
Fx Risk Should Be Monitored in Bisphosphonate Drug Holiday
Lower femoral neck bone mineral density and T scores for fracture versus non-fracture group
USPSTF Posts Osteoporosis Screening Recommendations
All women ≥65, high-risk postmenopausal women <65 should undergo bone measurement testing
Bone Strength + Bone Mineral Density Screening Cost-Effective
Model shows this combo starting at age 55 in postmenopausal women prevents fractures
Effect of Osteoporotic Fractures Similar to Diabetes Burden
Findings for quality of life with hip fractures, vertebral compression vs. vision loss, amputation
ASBMR: Romosozumab Reduces Fracture Rate in Osteoporosis
Reduced risk of new vertebral fractures, nonvertebral fractures for romosozumab and alendronate
Prevalence of Vertebral Fracture Varies With Assessment Method
Significantly different prevalence for quantitative morphometry, algorithm based qualitative methods
